The approval threshold is low, and the review time is short-


  who will guarantee the safety of "Xiao" brand products?

  Recently, some consumers reported that a baby skin care product suspected of triggering a "big head doll" incident has attracted widespread public opinion.

In order to avoid hormone drugs, some people who started as parents like to buy the so-called hormone-free skin care "magic medicine."

However, many so-called "magic drugs" actually add hormones in violation of regulations, and they have passed the approval with the "elimination" brand name, and exaggerated or even illegally promoted them in the market, posing great safety risks.

What is the difference between different approved products?

This incident revealed what regulatory loopholes existed in the "Xiao" brand products?

In the future, how can such product supervision be effective?

Our reporter conducted an investigation.

  "Xiao" font size, "makeup" font size, "medicine" font size:

  What are the differences between different approved products?

  "Is this the'makeup' font size or the'elimination' font size?" As the hormone-excess antibacterial cream incident continues to arouse concern, parents become nervous when buying baby cream.

  “Before buying face creams for children was bought online, mainly buying products with big names, high sales and high praise.” The 27-year-old Beijing Baoma Dingding has a 1-year-old baby. She told reporters that she would buy it for children. Most things are purchased online, some are planting grass on grass-growing software such as Xiaohongshu, and some are recommended by friends in the Baoma group.

"But I have also noticed that there are a lot of products on the e-commerce platform that have been ordered and praised. When I encounter such products, I will directly look at the question area to get a somewhat authentic evaluation." Ding Ding said, "This The'big head doll' incident is really scary. In the future, you must read the approval documents for your children and be cautious."

  On January 17, the "Ouai Antibacterial Cream" incident handling team in Zhangzhou City, Fujian Province issued a notice saying that after investigation and testing, it was confirmed that the two products involved contained hormones. The company was suspected of producing and selling fake and inferior products. The department has transferred relevant clues to the public security organs.

  The "big head doll" incident focused the public's attention on different production approvals such as "elimination" and "makeup": what is the difference between them?

  The reporter learned from the State Administration of Market Supervision and Administration that the "Xiao" brand products are external sanitary disinfectants with sanitary batch numbers that have been reviewed and approved by the health department. They include disinfectants and sanitary products, such as wet wipes, female menstrual hygiene products, and sanitary products. Masks, sanitary gloves, etc.

The "Disinfection Management Measures" stipulates that disinfection products mainly serve to kill and eliminate pathogenic microorganisms, and cannot show or suggest therapeutic effects.

"Xiao" brand products do not have the effect of regulating the physiological functions of the human body, and can neither claim to have curative effect nor curative effect. If a business claims that "Xiao" brand products have skin care effects, it is false propaganda.

  The "makeup" font size marked on cosmetics is the license mark obtained by non-special use cosmetics after being filed by the drug regulatory authority.

Moisturizing toners, lotions, creams, essences, foundations, lipsticks, eye shadows and other products used in daily skin care are all "makeup" brand products.

  "Medicine" refers to medicines, also known as "National Pharmaceutical Standards". It usually takes more than 3 years for the national drug regulatory authority to approve a "medicine" brand product, and 5 to 10 years is considered normal, and it has been strictly reviewed by the drug review experts. Approval only if the requirements are met.

In addition, a large number of qualitative inspections of product quality, pharmacodynamic experiments, pathological experiments, toxic and side-effect safety experiments and a large number of clinical experiments will be required during the approval period. Only drugs with a drug approval number can be produced and sold.

  Liu Xiangdong, deputy director of the Economic Research Department of the China Center for International Economic Exchange, pointed out that compared with more stringent "medicine" brand products, "xiao" brand products are relatively loose in approval.

"The license and management of'Xiao' brand products are mainly in the charge of the health administrative department below the provincial level. The approval time is usually about one month. The testing indicators are mainly sanitation and disinfection functions, and do not include pharmacology, pathology, side effects testing, and clinical verification. The review and approval." Liu Xiangdong said.

  Exaggerated publicity and high profits to seize the market:

  Some "eliminate" font size products play "edge ball"

  The short approval time and low approval threshold of "Xiao" brand products give unscrupulous merchants an opportunity.

Professor Zhou Qingjie of the School of Economics of Beijing Technology and Business University analyzed that the quality and safety incidents of "Big Tou Doll" revealed that some companies illegally added drugs to "Xiao" brand products to achieve a certain therapeutic effect, which was caused by malicious violations.

  "Natural and hormone-free", in order to cater to the psychology of novice parents who are reluctant to use hormone drugs, exaggerated publicity through the form of "scrubbing", this is the usual method of some "elimination" brand infant products." Zhou Qingjie said, "In the product manual of the bacteriostatic cream involved, it says'can be used for daily care.' This kind of publicity will mislead consumers into thinking that the product can be used for a long time."

  In addition to playing with word games, such products have repeatedly promoted that baby cream can "remove redness and relieve itching" and "repair every inch of baby's skin anytime, anywhere."

Zhou Qingjie pointed out that, according to national regulations, "Xiao" brand products must not be promoted as having therapeutic effects.

It does not have the corresponding treatment function, but falsely promotes and sells on social platforms, which seriously violates consumers' right to know, choose, and live and health.

  In fact, this "big head doll" incident is not the first case of "selling dog meat with sheep's head" and with different approval documents.

In 2019, Pudilan Keyanning antibacterial gargle and Pudilan Keyanning antibacterial gargle and Pudilan Keyanning antibacterial oral spray under the "Xiaozihao" product of Jichuan Pharmaceutical said that it can "adjuvant treatment" and "prevent disease" in external publicity. It was pointed out that it was suspected of false propaganda; the "Xiao" brand product "Dr. Ain" baby full-effect repair cream without any medical qualification certificate, wildly illegally promoted the curative effect, abruptly advocating disinfection products with only antibacterial effects into "Skin Medicine"...

  Wandering on the edge of the policy, on the one hand, enter the market through the "low threshold", on the other hand, exaggerate the use effect, mislead consumers, and use huge profit margins to seize the market. To some extent, the company involved in this incident "Reflects the survival of some "elimination" brand maternal and child products.

  In the sales link, such products seize the market through the lure of high profits.

It is understood that the outgoing price of the 25 grams of antibacterial cream involved is 4 yuan, but the market price is around 80 yuan, and there is a profit margin of more than 70 yuan, while 25 grams of antibacterial cream from a regular, well-known brand is only 30 yuan. about.

In addition, although the packaging and advertisements of "Xiao" brand products are not allowed to promote the therapeutic effect, in fact, some maternal and child stores have carried out a lot of oral sales to make money.

  Liu Xiangdong pointed out that from the repeated incidents of "Xiao" brand products, as daily consumer products, "Xiao" brand products have certain regulatory gaps.

"It is necessary to further improve the regulatory loopholes, especially to strengthen the approval and testing of the'elimination' font size, implement more standardized quality supervision certification, strictly investigate the three products that have not entered the market, and implement a strict recall system for problematic products." Liu Xiangdong said.

  Strengthen risk control and severely crack down on violations of laws and regulations:

  Strengthen supervision, consumers also pay more attention

  Safe products are produced and regulated.

Zhou Qingjie said that manufacturing companies are the first responsible persons for quality and safety, and the regulatory authorities must strictly implement national standards in their regulatory practices and crack down on violations of regulations and laws.

"Infant skin care products should be more stringent due to the particularity of the target users, whether it is the formulation of quality standards or the supervision of production." Zhou Qingjie said.

  The relevant person in charge of the State Administration for Market Regulation said that in order to strengthen the management of cosmetics registration and filing, protect consumers’ health rights, and standardize and promote the healthy development of the cosmetics industry, the newly issued “Administrative Measures for Cosmetics Registration and Filing” (hereinafter referred to as the “Measures”) will It will be implemented on May 1, 2021.

  The person in charge introduced that the "Measures" have a total of 63 articles, strictly review, review and record management, and strengthen risk control.

The first is to refine the management system of registrants and record holders to strengthen the implementation of the main responsibility of the enterprise; the second is to optimize the registration and record management procedures and implement the reform measures of the approval system; the third is to strengthen the supervision and management after filing to ensure that the responsibility for product quality and safety is in place.

Clarify the implementation of supervision and management responsibilities and work requirements after filing, increase the penalties for violations of the laws and regulations of filing products, implement hierarchical management of filing products, and rationally allocate supervision resources; fourth, establish a mechanism to encourage innovation and serve the high-quality development of the industry.

Strengthen the construction of registration and filing information, and build a multi-functional information service platform.

  Zhou Qingjie believes that regulatory authorities should use big data, blockchain and other means to improve the level of smart supervision and supervision efficiency, grasp the quality and safety information of market products in the first time, and block unsafe products from the market to the greatest extent.

Market circulation entities should standardize the procurement process and control product safety standards.

The manufacturer of the enterprise shall specify the relevant functions in the product instruction manual.

  In addition to companies producing products in accordance with regulations and regulatory agencies to improve regulatory efficiency, consumers should also be vigilant and choose products carefully.

  Experts suggest that consumers should pay attention to the improvement of their own scientific literacy and market knowledge, distinguish the functions of consumer products and medicines, understand the channel characteristics of different products, and grasp the correspondence between price levels and quality.

"Consumers should pay attention to brand and reputation when purchasing products, use new products with caution, and when using new products, they must carefully read the instructions, check the composition and efficacy of the product, check the origin and expiration date, especially products that involve personal health. Use it with caution." Liu Xiangdong said, "At the same time, we must promptly safeguard the rights of problematic products and understand the necessary traceability channels for products."

Kong Dechen

Kong Dechen